Home > Healthcare > Analytical Instruments > Elemental Analysis > Label-free Array Systems Market

Label-free Array Systems Market Share

Report ID: GMI9649
Published Date: May 2024
Report Format: PDF

Download Free Sample

Label-free Array Systems Market Share

The label-free array systems industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive products and techniques with improved efficiency and affordability. This includes advancements in processing, precision, automation, and customization. Competition is driven by factors such as the quality, reliability, and ease of usage along with integration capabilities with existing technologies, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Label-free Array Systems Market Companies

Some of the eminent market participants operating in the label-free array systems industry include:

Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Corning Incorporated
Danaher Corporation
F. Hoffmann-La Roche AG
Illumina, Inc.
Merck KGaA
Meso Scale Diagnostics (MSD)
Nanion Technologies
Pall Corporation
PerkinElmer, Inc.
Sartorius AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global label-free array systems industry size was valued at USD 1.4 billion in 2023 and is estimated to grow at 7.2% CAGR from 2024 to 2032 due to increasing drug discovery and development activities and rising cases of chronic and infectious diseases.

The surface plasmon resonance (SRP) segment in the market is estimated to account for USD 669.2 million by 2032 because SRP technology offers sensitive and label-free detection of biomolecular interactions.

The drug discovery segment of the label-free array systems market accounted for USD 483.6 million in 2023 due to screening large libraries of compounds to identify potential drug candidates and the ability to conduct real-time analysis.

Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Danaher Corporation, F. Hoffmann-La Roche AG, Illumina, Inc., Merck KGaA, Meso Scale Diagnostics (MSD), Nanion Technologies, and Pall Corporation, among others.